首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

免疫組織化學介質市場規模、佔有率和成長分析：按產品類型、應用、最終用戶、技術、檢體類型和地區分類 - 2026-2033 年行業預測

市場調查報告書

商品編碼

1964215

免疫組織化學介質市場規模、佔有率和成長分析：按產品類型、應用、最終用戶、技術、檢體類型和地區分類 - 2026-2033 年行業預測

Immunohistochemistry Transmitter Market Size, Share, and Growth Analysis, By Product Type, By Application, By End User, By Technology, By Specimen Type, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024年全球免疫組織化學介質市場價值為25億美元，預計2025年將成長至26.9億美元，2033年將成長至47.9億美元。預測期（2026-2033年）的複合年成長率預計為7.5%。

全球免疫組化檢測市場的主要驅動力是腫瘤學領域對精準組織診斷日益成長的需求，尤其是在治療方法越來越注重生物標記的情況下。抗體、檢測試劑和自動化染色系統等關鍵產品能夠增強組織內蛋白質表現的可視化，這對於制定明智的治療決策至關重要。從手工染色到自動化系統的演變顯著提高了可重複性，乳癌HER2檢測便是明證。自動化、多層次免疫組化和數位病理學的整合正在推動醫院和實驗室加強投資，以加快檢體處理速度並降低變異性。此外，人工智慧技術透過標準化染色判讀、輔助病理學家以及簡化工作流程來提高診斷準確性，最終推動免疫組化領域的成長，並吸引製藥公司與其建立合作關係。

全球免疫組化傳輸市場促進因素

癌症發生率的上升和公眾對疾病認知的提高，正顯著推動免疫組織化學 (IHC) 檢測需求的成長。隨著實驗室和醫院不斷努力提升診斷能力，採用先進的 IHC 發射器對於簡化工作流程和支援生物標記的識別至關重要。對精準的組織學診斷和有效治療方案選擇的日益重視，正推動著對先進設備及相關服務的投資。此外，臨床團隊也越來越需要更快、更可靠的染色和影像處理流程來指導治療決策。這種對精準診斷的持續需求，促使製造商不斷創新產品線，拓展分銷網路，從而促進更廣泛的市場接受度，並在臨床和研究領域實現永續成長。

全球免疫組織化學傳輸市場的限制因素

全球免疫組織傳輸設備市場面臨的主要挑戰是抗體、檢測試劑盒和一次性耗材的高成本，增加了醫療機構和實驗室的整體擁有成本。因此，許多機構可能會推遲採購或限制檢測量以符合預算限制。資源有限的小規模實驗室往往專注於基本服務，而不是投資先進設備的升級，導致市場滲透率較低。此外，耗材的持續成本阻礙了依賴專有試劑的冗餘和自動化功能的應用，進一步阻礙了對營運成本敏感的細分市場的廣泛應用和成長。這種趨勢往往有利於大規模機構進行設備採購。

全球免疫組化傳輸劑市場趨勢

隨著數位病理技術的日益融合，全球免疫組化傳輸器市場也不斷發展。檢查室正採用全切片成像和數位化工作流程來提高營運效率。這一趨勢凸顯了對能夠實現無縫互通性和資料交換的傳輸器日益成長的需求，從而促進集中式影像閱片和遠端會診。為此，供應商正在開發能夠與實驗室資訊系統和人工智慧工具無縫整合的系統，並專注於標準化的通訊協定和使用者友好的介面。隨著對軟硬體協同開發的日益重視，策略合作夥伴關係正在湧現，旨在提供能夠提高診斷準確性和檢查室靈活性的全面數位化解決方案。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場公司採取的策略
近期市場趨勢
企業市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 2023-2025年營收年比比較

主要企業簡介

Abcam
Cell Signaling Technology
Bio-Rad Laboratories
Thermo Fisher Scientific
Merck KGaA
PerkinElmer
F. Hoffmann-LA Roche AG
Agilent Technologies
Sino Biological
BioGenex
Bio SB
Dako（part of Agilent Technologies）
Leica Biosystems
ProtoLabs
GeneTex
R&D Systems
In Situ Biologics
Advanced Cell Diagnostics
Epredia
Biocare Medical

結論與建議

簡介目錄

Product Code: SQMIG35J2193

Global Immunohistochemistry Transmitter Market size was valued at USD 2.5 Billion in 2024 and is poised to grow from USD 2.69 Billion in 2025 to USD 4.79 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The Global Immunohistochemistry Transmitter Market is significantly driven by the rising need for accurate tissue-based diagnostics in oncology, particularly as therapies increasingly focus on biomarkers. Key products like antibodies, detection chemistries, and automated stainers enhance the visualization of protein expression in tissues, crucial for informed treatment decisions. The evolution from manual staining to automated systems has substantially improved reproducibility, evident in tests like HER2 for breast cancer. The integration of automation, multiplex IHC, and digital pathology accelerates sample processing and reduces variability, encouraging investments across hospitals and laboratories. Additionally, AI technologies are enhancing diagnostic accuracy by standardizing stain interpretation, assisting pathologists, and streamlining workflows, ultimately fostering growth and attracting pharmaceutical partnerships in the immunohistochemistry landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunohistochemistry Transmitter market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunohistochemistry Transmitter Market Segments Analysis

Global immunohistochemistry transmitter market is segmented by product type, application, end user, technology, specimen type and region. Based on product type, the market is segmented into Antibodies, Reagents, Instruments and Kits. Based on application, the market is segmented into Research Applications, Diagnostic Applications, Pharmaceutical Applications and Pathological Assessment. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical Companies and Biotechnology Companies. Based on technology, the market is segmented into Fluorescence-based IHC, Enzyme-based IHC, Chromogenic IHC and Multiplex IHC. Based on specimen type, the market is segmented into Tissue Specimens, Blood Specimens, Cell Lines and Organoid Models. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunohistochemistry Transmitter Market

The rising incidence of cancer, coupled with heightened awareness surrounding the disease, has significantly boosted the demand for immunohistochemistry assays. As laboratories and hospitals strive to enhance their diagnostic capabilities, the acquisition of advanced IHC transmitters has become essential for improving workflows and aiding in biomarker identification. The growing emphasis on precise tissue-based diagnostics and effective therapy selection drives investment in advanced instrumentation and ancillary services. Furthermore, clinical teams are increasingly demanding quicker and more reliable staining and imaging processes to inform treatment decisions. This ongoing need for accurate diagnostics propels manufacturers to innovate their product lines and broaden distribution networks, fostering greater market acceptance and sustained growth in both clinical and research environments.

Restraints in the Global Immunohistochemistry Transmitter Market

The Global Immunohistochemistry Transmitter market faces challenges primarily due to the high costs associated with antibodies, detection kits, and single-use consumables, which raise the overall ownership expenses for healthcare facilities and laboratories. As a result, many institutions may postpone purchases or restrict testing volumes to adhere to budget constraints. Smaller laboratories with limited resources tend to focus on essential services instead of investing in advanced instrument upgrades, leading to reduced market penetration. Additionally, the ongoing expenses related to consumables hinder the adoption of multiplexing and automation features that depend on proprietary reagents, further impeding widespread implementation and growth in operationally sensitive market segments. This trend tends to favor larger institutions for equipment purchases.

Market Trends of the Global Immunohistochemistry Transmitter Market

The Global Immunohistochemistry Transmitter market is increasingly shaped by the integration of digital pathology technologies, as laboratories embrace whole slide imaging and digital workflows to enhance operational efficiencies. This trend underscores a growing need for transmitters that facilitate seamless interoperability and data exchange, allowing for centralized image review and remote consultations. Providers are responding by developing systems that integrate smoothly with laboratory information systems and artificial intelligence tools, emphasizing standardized communication protocols and user-friendly interfaces. As the emphasis on co-development of software and hardware increases, strategic partnerships are emerging to deliver comprehensive digital solutions that improve diagnostic accuracy and laboratory agility.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Immunohistochemistry Transmitter Market Size by Product Type & CAGR (2026-2033)

Market Overview
Antibodies
- Primary Antibodies
- Secondary Antibodies
Reagents
Instruments
Kits

Global Immunohistochemistry Transmitter Market Size by Application & CAGR (2026-2033)

Market Overview
Research Applications
Diagnostic Applications
Pharmaceutical Applications
Pathological Assessment

Global Immunohistochemistry Transmitter Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Laboratories
Academic & Research Institutes
Pharmaceutical Companies
Biotechnology Companies

Global Immunohistochemistry Transmitter Market Size by Technology & CAGR (2026-2033)

Market Overview
Fluorescence-based IHC
Enzyme-based IHC
Chromogenic IHC
Multiplex IHC

Global Immunohistochemistry Transmitter Market Size by Specimen Type & CAGR (2026-2033)

Market Overview
Tissue Specimens
Blood Specimens
Cell Lines
Organoid Models

Global Immunohistochemistry Transmitter Market Size & CAGR (2026-2033)

North America (Product Type, Application, End User, Technology, Specimen Type)
- US
- Canada
Europe (Product Type, Application, End User, Technology, Specimen Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, End User, Technology, Specimen Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, End User, Technology, Specimen Type)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, End User, Technology, Specimen Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abcam
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann- LA Roche AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sino Biological
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioGenex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio SB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dako (part of Agilent Technologies)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leica Biosystems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ProtoLabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneTex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
R&D Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
In Situ Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Cell Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epredia
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocare Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments